Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Silo Pharma, Inc.
| Metric | Silo Pharma, Inc. SILOOther |
|---|---|
| Quality Score | 35 / 100 |
| Revenue (latest) | $72,102 |
| Net income (latest) | −$4M |
| Operating margin | −5937.0% |
| Net margin | −5863.5% |
| Return on equity | −67.0% |
| Return on assets | −55.6% |
| Return on capital (ROCE) | −61.5% |
| Debt / equity | 0.21× |
| Revenue growth (YoY) | 0.0% |
| Altman Z″ (distress) | -1.23 |
| Accruals / assets | 5.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.